Skip to main content
NDRA
NASDAQ Industrial Applications And Services

ENDRA Life Sciences Finalizes Definitive Merger Agreement with Noble Africa, Securing $50M Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
10
Price
$4.46
Mkt Cap
$5.461M
52W Low
$2.96
52W High
$11.96
52W Position info
51% above low
Off High info
63% below high
Rel. Volume info
17× avg
Market data snapshot near publication time

NDRA sits 51% above its 52-week low of $2.96 on elevated volume (17× avg).

Summary

ENDRA Life Sciences, a distressed company, has finalized a merger with Noble Africa, a helium company, securing $50 million in financing and a new business direction, subject to shareholder approval and a potential reverse stock split.


Key Events · M&A and Partnerships · NDRA

  • Definitive Merger Agreement

    ENDRA's subsidiary will merge with Noble Africa LLC, a helium company, with Noble Africa surviving as a wholly-owned subsidiary of ENDRA. The agreement was finalized on June 25, 2026.

  • $50 Million Private Placement

    Noble Africa secured approximately $50 million in gross proceeds from a private placement at $6.57 per unit, providing substantial capital for the combined entity.

  • New Capital Structure and Control

    The combined company will be renamed Noble Africa Inc. and will implement a dual-class stock structure, with Class B shares (held by ASP Isotopes Inc.) carrying 10 votes per share, concentrating voting power.

  • Nasdaq Compliance & Cash Requirement

    A reverse stock split is contemplated to maintain Nasdaq listing compliance, and ENDRA must hold at least $3.8 million in cash at closing.


Analysis · NDRA · Industrial Applications And Services

ENDRA Life Sciences, a company previously facing a Nasdaq delisting notice and a going concern warning, has finalized a definitive merger agreement with Noble Africa LLC, a helium company. This transformational transaction includes a $50 million private placement into Noble Africa, providing critical capital that is approximately nine times ENDRA's current market capitalization. The combined entity will be renamed Noble Africa Inc. and will adopt a dual-class stock structure, concentrating significant voting power with ASP Isotopes Inc. This merger fundamentally alters ENDRA's business and financial outlook, offering a path to survival and a new strategic direction.

At the time of this filing, NDRA was trading at $4.46 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $2.96 to $11.96. This filing was assessed with positive market sentiment and an importance score of 10 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NDRA - Latest Insights

NDRA
Jul 09, 2026, 6:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.73
Real-time Price: $4.60 info
Change: -$0.130 (-3%) info
Market Cap: $5.842M info
NDRA
Jul 09, 2026, 6:08 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.73
Real-time Price: $4.60 info
Change: -$0.130 (-3%) info
Market Cap: $5.842M info
NDRA
Jun 29, 2026, 9:29 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $4.60 info
Change: -$0.400 (-8%) info
Market Cap: $5.842M info
NDRA
Jun 26, 2026, 6:13 AM EDT
Source: Wiseek News
Importance Score:
10
Price at Filing: $4.46
Real-time Price: $4.60 info
Change: +$0.140 (+3%) info
Market Cap: $5.842M info
NDRA
Jun 26, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $4.46
Real-time Price: $4.60 info
Change: +$0.140 (+3%) info
Market Cap: $5.842M info